MAP1Bmicrotubule associated protein 1B
Autism Reports / Total Reports
7 / 14Rare Variants / Common Variants
17 / 0Aliases
-Associated Syndromes
ASD, Fragile X syndrome, Fragile X syndromeChromosome Band
5q13.2Associated Disorders
-Relevance to Autism
De novo variants in the MAP1B gene, including three loss-of-function variants, have been reported in individuals with a clinical diagnosis of ASD (De Rubeis et al., 2014; Satterstrom et al., 2020; Zhou et al., 2022; Spataro et al., 2023). Heterozygous mutations in MAP1B are also responsible for periventricular nodular heterotopia-9 (OMIM 618918), an autosomal dominant neurologic disorder characterized by malformation of cortical development (including anterior predominant PVNH, thin corpus callosum, and decreased white matter volume), developmental delay, cognitive defects associated with low IQ (range 50 to 80), learning disabilities, seizures, and behavior abnormalities; autism spectrum disorder was reported in a subset of affected individuals with this disorder (Heinzen et al., 2018; Walters et al., 2018; Julca et al., 2019; Arya et al., 2021). MAP1B has been shown to interact with FMRP, the protein encoded by the FMR1 gene, as well as with the protein encoded by the KIRREL3 gene (Zhang et al., 2001; Liu et al., 2015).
Molecular Function
This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1B heavy chain and LC1 light chain. Gene knockout studies of the mouse microtubule-associated protein 1B gene suggested an important role in development and function of the nervous system.
External Links
SFARI Genomic Platforms
Reports related to MAP1B (14 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | - | Zhang YQ et al. (2001) | No | - |
2 | Support | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
3 | Support | - | Liu YF et al. (2015) | No | - |
4 | Support | - | Heinzen EL et al. (2018) | No | DD, ID, epilepsy/seizures |
5 | Support | - | Walters GB et al. (2018) | No | ASD |
6 | Support | - | Julca DM et al. (2019) | No | ADHD, DD, ID, epilepsy/seizures |
7 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
8 | Support | - | Arya R et al. (2021) | No | DD, epilepsy/seizures |
9 | Support | - | Zhou X et al. (2022) | Yes | - |
10 | Primary | - | Spataro N et al. (2023) | Yes | - |
11 | Recent Recommendation | - | Guo Y et al. (2023) | Yes | - |
12 | Support | - | Cirnigliaro M et al. (2023) | Yes | - |
13 | Support | - | Sheth F et al. (2023) | Yes | DD, ID |
14 | Support | - | Salima Messaoudi et al. (2024) | No | - |
Rare Variants (17)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | copy_number_gain | Unknown | Not maternal | - | 37365192 | Guo Y et al. (2023) | |
c.1951G>T | p.Glu651Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2035G>T | p.Glu679Ter | stop_gained | De novo | - | - | 31317654 | Julca DM et al. (2019) | |
c.-10+32G>A | - | intron_variant | De novo | - | - | 31981491 | Satterstrom FK et al. (2020) | |
c.2995C>T | p.Arg999Ter | stop_gained | De novo | - | - | 36980980 | Spataro N et al. (2023) | |
c.907C>T | p.Arg303Ter | stop_gained | De novo | - | - | 29738522 | Heinzen EL et al. (2018) | |
c.5875A>G | p.Ile1959Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1456C>T | p.Arg486Ter | stop_gained | De novo | - | - | 31981491 | Satterstrom FK et al. (2020) | |
c.1912G>T | p.Val638Leu | missense_variant | De novo | - | - | 25363760 | De Rubeis S , et al. (2014) | |
c.1594C>T | p.Gln532Ter | stop_gained | Familial | Paternal | - | 29738522 | Heinzen EL et al. (2018) | |
c.7157T>C | p.Val2386Ala | missense_variant | Unknown | - | Simplex | 37543562 | Sheth F et al. (2023) | |
c.3316C>T | p.Arg1106Ter | stop_gained | Familial | Maternal | - | 29738522 | Heinzen EL et al. (2018) | |
c.4990C>T | p.Arg1664Ter | stop_gained | Familial | Maternal | Simplex | 30150678 | Walters GB et al. (2018) | |
c.3094G>T | p.Glu1032Ter | stop_gained | Familial | Maternal | Multiplex | 30150678 | Walters GB et al. (2018) | |
c.441del | p.Leu148CysfsTer4 | frameshift_variant | Familial | Paternal | - | 29738522 | Heinzen EL et al. (2018) | |
c.5793T>G | p.Tyr1931Ter | stop_gained | Familial | Maternal | Multiplex | 37506195 | Cirnigliaro M et al. (2023) | |
c.1756del | p.Glu586LysfsTer10 | frameshift_variant | Familial | Maternal | Multi-generational | 30150678 | Walters GB et al. (2018) |
Common Variants
No common variants reported.
SFARI Gene score
Strong Candidate
Score Delta: Score remained at 2
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
7/1/2023
Increased from to 2
Krishnan Probability Score
Score 0.60780319606539
Ranking 300/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.9999862477961
Ranking 483/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.94911675528766
Ranking 17960/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.092684067081662
Ranking 6284/20870 scored genes
[Show Scoring Methodology]